Tags

Type your tag names separated by a space and hit enter

Outcome of horses with enterocolitis receiving oncotic fluid support with either plasma or hetastarch.
Can Vet J 2019; 60(11):1207-1212CV

Abstract

The objective of this study was to determine whether there was an association between type of colloid administered and survival of horses with enterocolitis (N = 92). A retrospective review of medical records of horses with enterocolitis treated with plasma or hetastarch (HES) between January 1, 2005 and December 31, 2011 was performed. Data collected included signalment, outcome, physical and clinicopathologic findings, and volume and type of colloid administered. Sixty-nine horses (75%) were treated with plasma and 23 horses (25%) were treated with HES. After accounting for confounding variables, horses treated with plasma (80% survival) were more likely to survive to discharge than horses treated with HES (47% survival; P = 0.041) despite similar disease severity at admission. This study provides support that use of natural colloids may be superior to treatment with synthetic colloids in horses with enterocolitis. A prospective, multi-center trial comparing outcome of critically ill equine patients treated with natural or synthetic colloids is warranted.

Authors+Show Affiliations

Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA (Kopper, Cook, Schott II); Center for Interdisciplinary Statistical Education and Research, Washington State University, Pullman, Washington, USA (Kogan).Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA (Kopper, Cook, Schott II); Center for Interdisciplinary Statistical Education and Research, Washington State University, Pullman, Washington, USA (Kogan).Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA (Kopper, Cook, Schott II); Center for Interdisciplinary Statistical Education and Research, Washington State University, Pullman, Washington, USA (Kogan).Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA (Kopper, Cook, Schott II); Center for Interdisciplinary Statistical Education and Research, Washington State University, Pullman, Washington, USA (Kogan).

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31692633

Citation

Kopper, Jamie J., et al. "Outcome of Horses With Enterocolitis Receiving Oncotic Fluid Support With Either Plasma or Hetastarch." The Canadian Veterinary Journal = La Revue Veterinaire Canadienne, vol. 60, no. 11, 2019, pp. 1207-1212.
Kopper JJ, Kogan CJ, Cook VL, et al. Outcome of horses with enterocolitis receiving oncotic fluid support with either plasma or hetastarch. Can Vet J. 2019;60(11):1207-1212.
Kopper, J. J., Kogan, C. J., Cook, V. L., & Schott, H. C. (2019). Outcome of horses with enterocolitis receiving oncotic fluid support with either plasma or hetastarch. The Canadian Veterinary Journal = La Revue Veterinaire Canadienne, 60(11), pp. 1207-1212.
Kopper JJ, et al. Outcome of Horses With Enterocolitis Receiving Oncotic Fluid Support With Either Plasma or Hetastarch. Can Vet J. 2019;60(11):1207-1212. PubMed PMID: 31692633.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Outcome of horses with enterocolitis receiving oncotic fluid support with either plasma or hetastarch. AU - Kopper,Jamie J, AU - Kogan,Clark J, AU - Cook,Vanessa L, AU - Schott,Harold C,2nd PY - 2020/05/01/pmc-release PY - 2019/11/7/entrez PY - 2019/11/7/pubmed PY - 2019/11/7/medline SP - 1207 EP - 1212 JF - The Canadian veterinary journal = La revue veterinaire canadienne JO - Can. Vet. J. VL - 60 IS - 11 N2 - The objective of this study was to determine whether there was an association between type of colloid administered and survival of horses with enterocolitis (N = 92). A retrospective review of medical records of horses with enterocolitis treated with plasma or hetastarch (HES) between January 1, 2005 and December 31, 2011 was performed. Data collected included signalment, outcome, physical and clinicopathologic findings, and volume and type of colloid administered. Sixty-nine horses (75%) were treated with plasma and 23 horses (25%) were treated with HES. After accounting for confounding variables, horses treated with plasma (80% survival) were more likely to survive to discharge than horses treated with HES (47% survival; P = 0.041) despite similar disease severity at admission. This study provides support that use of natural colloids may be superior to treatment with synthetic colloids in horses with enterocolitis. A prospective, multi-center trial comparing outcome of critically ill equine patients treated with natural or synthetic colloids is warranted. SN - 0008-5286 UR - https://www.unboundmedicine.com/medline/citation/31692633/Outcome_of_horses_with_enterocolitis_receiving_oncotic_fluid_support_with_either_plasma_or_hetastarch DB - PRIME DP - Unbound Medicine ER -
Unbound Prime app for iOS iPhone iPadUnbound PubMed app for AndroidAlso Available:
Unbound MEDLINE
Unbound PubMed app for Windows